Disease

Obesity

Review Report on Obesity Target / Biomarker Content of Review Report on Obesity Target / Biomarker
Obesity


About the Disease
Body Mass Index Quantitative Trait Locus 11, also known as obesity, is related to leptin deficiency or dysfunction and type 2 diabetes mellitus, and has symptoms including high weight, symptoms and obesity, metabolically benign. An important gene associated with Body Mass Index Quantitative Trait Locus 11 is UCP3 (Uncoupling Protein 3), and among its related pathways/superpathways are Beta-2 adrenergic-dependent CFTR expression and Glucose / Energy Metabolism. The drugs Hydrocortisone and Hydrocortisone succinate have been mentioned in the context of this disorder. Affiliated tissues include skeletal muscle, liver and heart, and related phenotypes are obesity and decreased resting energy expenditure

Common Targets
cAMP Responsive Element Binding Protein (CREB) (nonspecified subtype) | G659 | G5156 | G8513 | P10999 | G3635 | G5122 | G240 | G9388 | G11133 | G6531 | G200150 | G2247 | G25878 | G100996758 | G93145 | G5724 | CCK receptor (nonspecified subtype) | G388324 | G4129 | G7428 | G7494 | G9369 | G10580 | G327 | G3458 | Phosphodiesterase 6 (PDE6) (nonspecified subtype) | G9644 | G762 | G27241 | G2740 | G2885 | G55554 | G11001 | G983 | G5919 | G348 | G6934 | G9414 | G5743 | Monoamine oxidase (MAO) (nonspecified subtype) | G5409 | G283455 | G3359 | G7352 | G4883 | G2642 | G10954 | P16740 | G64116 | G3671 | G148811 | G3767 | G7048 | G4753 | G54898 | G284361 | G8986 | G2931 | G158038 | G862 | G11186 | G2322 | G5373 | G3565 | Interleukin-1 receptor-associated kinase (IRAK) (nonspecified subtype) | G6720 | G6351 | G399669 | G432 | G50832 | G84134 | G5777 | Phosphodiesterase (nonspecified subtype) | G124274 | G25880 | G2950 | G11200 | G5920 | Acetyl-CoA Carboxylases (ACC) (nonspecified subtype) | Diacylglycerol Acyltransferase (DGAT) (nonspecified subtype) | G1535 | G51076 | G54386 | NADPH Oxidase (nonspecified subtype) | G6331 | G4524 | G22933 | G5052 | G930 | G948 | G11091 | Fibroblast Growth Factor Receptor (FGFR) (nonspecified subtype) | G847 | G10531 | G3162 | G6524 | G1588 | Histone deacetylase (nonspecified subtype) | G4292 | G4312 | G23178 | G238 | G9290 | Prostaglandin EP Receptor (nonspecified subtype) | G54112 | G8658 | G9682 | G132 | G6401 | G3636 | G6416 | P6747 | G406922 | G89866 | G1454 | G6929 | G6000 | G9646 | G11138 | G4194 | G8291 | G5168 | G3572 | G1845 | G7100 | G860 | G1071 | Calcium/calmodulin-dependent protein kinase (nonspecified subtype) | G23017 | G23322 | G50839 | G5294 | G57558 | Corticotropin-Releasing Factor (CRF) Receptor (nonspecified subtype) | Mitogen-activated protein kinase p38 (MAPK p38) (nonspecified subtype) | G406923 | G83451 | G5478 | G9415 | G3294 | G4023 | G8740 | G11255 | P13024 | Carnitine O-Palmitoyltransferase 1 (CPT-1) (nonspecified subtype) | G139760 | G1499 | G151306 | G196475 | G5599 | G145482 | G1909 | G4353 | G50617 | G2350 | G5771 | Cyclin B (nonspecified subtype) | G338557 | G3718 | 5-Hydroxytryptamine Receptor 3 (5-HT3 receptor) (nonspecified subtype) | G6647 | G6870 | G80168 | G80789 | G130399 | Serum/glucocorticoid regulated kinase (Sgk) (nonspecified subtype) | G6865 | G4915 | G5243 | G1010 | G2936 | G644524 | G440034 | G493856 | G51129 | G5144 | G51738 | G2597 | G105373234 | G596 | G1548 | G7248 | G5651 | G10963 | Kainate Receptor (GluR) (nonspecified subtype) | G6622 | G6790 | G27130 | G8854 | G105373238 | G2308 | G9518 | G763 | G800 | G2736 | G105375494 | G1408 | G83463 | G5163 | G1026 | G54971 | G10715 | G552 | G105373353 | G6097 | G1581 | G2191 | G7423 | G2288 | G2905 | G627 | G79083 | G54511 | G2897 | G57787 | Mitogen-Activated Protein Kinase (MAP Kinase)-Activated Protein Kinase (nonspecified subtype) | G3949 | G6752 | G4157 | G2162 | G6571 | G23040 | G81797 | G1610 | G4149 | G80307 | G25 | G2872 | G114548 | G51447 | G25970 | P16165 | G7037 | G8694 | G574441 | G1662 | G682 | G5062 | G9970 | G3738 | G3791 | G2271 | G51185 | G51289 | G2915 | G63976 | G6423 | G169792 | G2864 | G92565 | Neuropeptide Y receptor (NPY-R) (nonspecified subtype) | Serine/Threonine Kinase (nonspecified subtype) | G3576 | G1956 | G203238 | G221395 | G22880 | G253559 | G2693 | G100126793 | G4247 | G79190 | G9355 | G3593 | G169841 | Carbonic Anhydrase (nonspecified subtype) | G4543 | G2976 | G5590 | G11145 | Glycogen phosphorylase (nonspecified subtype) | G132320 | G6439 | G388566 | G1589 | G22837 | G3238 | G112609 | LanC-like proteins (nonspecified subtype) | G181 | G4886 | G100526783 | G11261 | G5791 | G132321 | G1646 | G7068 | G79191 | G1017 | G285973 | G3181 | G583 | G1582 | G387129 | G52 | G2784 | G54979 | G60675 | G157680 | G6608 | G152831 | G389400 | G2217 | G80339 | G8824 | G29881 | P10238 | Tyrosine-Protein Kinases Src (nonspecified subtype) | G643911 | G3717 | G9321 | G56651 | G120892 | CDK5/p25 | G3958 | G407040 | G51292 | G252995 | G10265 | G10419 | G1815 | G4306 | G218 | G4986 | G283219 | G5563 | G1277 | Interleukin-1 (nonspecified subtype) | G151 | G1549 | G2695 | G2841 | G3551 | G3752 | G6526 | Thyroid hormone receptor (nonspecified subtype) | G8140 | G109 | G7376 | G5164 | G56940 | G1201 | G59272 | G3700 | G2263 | G79705 | G11322 | G765 | G79001 | G25897 | G553 | G3163 | G9915 | G11343 | G6480 | G1958 | G5443 | G10869 | Sodium-Glucose Cotransporter (SGLT) (nonspecified subtype) | G5142 | G83853 | G27329 | G91147 | G5792 | G374 | G6829 | G84649 | G8660 | G9370 | G57498 | G1/S-specific cyclin-E (nonspecified subtype) | G2645 | G2865 | G30845 | G3111 | G183 | G7124 | G239 | G5587 | G1374 | G219578 | G84654 | G3620 | G2053 | G23765 | Hedgehog Protein (nonspecified subtype) | P11019 | G6319 | G1520 | G4869 | G5313 | G55690 | P5859 | G1586 | Phospholipase A2 (nonspecified subtype) | G5137 | G5578 | Cholesterol esterase (nonspecified subtype) | G6446 | G187 | G207 | G759 | G255239 | G55902 | Casein kinase I (nonspecified subtype) | Mucin (nonspecified subtype) | G695 | G4988 | G1050 | G121130 | G7224 | G7357 | Heat shock protein 90 (nonspecified subtype) | G4217 | G8800 | G3274 | G1153 | Phosphodiesterase IV (PDE4) (nonspecified subtype) | G259290 | G9156 | G949 | G6386 | G4015 | G771 | G864 | G1021 | G3091 | G955 | G9619 | P38821 | Alpha-2 Adrenergic receptors (nonspecified subtype) | G51654 | G10266 | G3479 | ADP-Ribosyl Cyclase/cyclic ADP-Ribose Hydrolase (ADPRC) (nonspecified subtype) | G6708 | G6774 | G10062 | G6198 | G6753 | G4296 | G25825 | G8484 | G116085 | G3795 | G6638 | G4314 | G7174 | G25791 | G2590 | G887 | G55506 | Protein Kinase B (PKB/Akt) (nonspecified subtype) | G1991 | G2532 | G9356 | G1072 | G1636 | G5063 | G105371268 | G3164 | Fibroblast growth factor (FGF) (nonspecified subtype) | G598 | G6046 | P38822 | G3726 | G51742 | G8569 | G2688 | G2912 | G5780 | G1816 | G217 | G2280 | G80731 | G8785 | G105371269 | G3061 | P38823 | G3932 | G1959 | G4321 | G7189 | G846 | G5728 | G152007 | G442890 | G23362 | G105371273 | G3417 | P12327 | G5950 | G1432 | G404266 | G4654 | G253782 | G259293 | G9358 | G114821 | G7040 | G5465 | G3297 | G1385 | Calcium channel (nonspecified subtype) | Matrix Metalloproteinase (MMP) (nonspecified subtype) | G3952 | G5152 | G27339 | G105371274 | G10846 | G1135 | P38824 | G10267 | G55829 | G3553 | G442898 | G5460 | G10211 | G105371275 | Lipoxygenase (nonspecified subtype) | G1269 | G6609 | G7299 | G79596 | G23452 | G80834 | G5146 | G5481 | G1020 | G9020 | P19243 | G7295 | G2494 | G8396 | G105371276 | G572 | G140609 | G146664 | Phosphatidylinositol 3-kinase (PI3K) (nonspecified subtype) | G1436 | G6536 | G7074 | G4887 | G10488 | G105371278 | G6464 | G79885 | G91408 | G3727 | G1571 | G4536 | G53345 | G55212 | G2892 | G105371279 | G3375 | G7465 | G10797 | G136 | G64400 | G9817 | P12578 | G5166 | G1019 | Protein Tyrosine Phosphatase (PTP) (nonspecified subtype) | Opioid receptor (nonspecified subtype) | G155 | G7150 | G463 | G54878 | G9559 | G3357 | G345 | G1312 | G377677 | Neurotrophic Factor (nonspecified subtype) | Oxysterols receptor LXR (nonspecified subtype) | Acetylcholine Receptors (Nicotinic) (nAChR) (nonspecified subtype) | G1647 | G6926 | G10320 | G56106 | G3350 | G5795 | G3569 | P34664 | Peroxisome Proliferator-Activated Receptors (PPAR) (nonspecified subtype) | G5604 | G30815 | G5836 | G60684 | G134 | G2100 | G7412 | G129880 | G6530 | G7433 | G80184 | G2867 | P16176 | G3815 | G4128 | G51523 | G57678 | P24881 | G5170 | G255738 | G53632 | G4734 | G3156 | G1813 | G4878 | G766 | G79058 | G23411 | G81631 | G83869 | G8804 | G132789 | G100379251 | G2876 | G10363 | G9376 | G113277 | G164781 | G1910 | G4544 | G4780 | G7718 | G1139 | G719 | G140885 | G729993 | G4738 | G8856 | G55599 | G143689 | G196883 | G7535 | G2624 | G2696 | G50650 | G19 | G23476 | G54814 | G5583 | G3383 | Histone acetyltransferase (HAT) (nonspecified subtype) | G590 | G150 | G429 | G4987 | G5241 | G5293 | G29803 | G51393 | G127018 | P5867 | G6648 | G1859 | G4159 | G7514 | G1025 | Orexin receptor (nonspecified subtype) | P6058 | G1591 | G5540 | P11113 | G340024 | DNA Topoisomerase II (nonspecified subtype) | G4620 | G2868 | G6344 | G3643 | P6320 | G4046 | G22852 | G4916 | G8001 | G6391 | G4094 | G7021 | G4852 | G23788 | G1051 | G952 | G3250 | Taste receptor type 2 (nonspecified subtype) | G216 | G79890 | G54543 | G10159 | G2990 | G5601 | G1268 | G3938 | Na+/K+-ATPase (nonspecified subtype) | G200576 | G729230 | G9261 | G57406 | Glucagon-like peptide receptor (GLP-R) (nonspecified subtype) | G4829 | G5079 | G51135 | G10060 | G6095 | Estrogen receptor (nonspecified subtype) | G2171 | G4889 | G2309 | G8462 | G101927087 | G3074 | G1066 | G56670 | G958 | MAP Kinase-Interacting Serine/Threonine-Protein Kinase (nonspecified subtype) | G9021 | G5565 | G5617 | G5467 | G3290 | G93 | G3213 | G4316 | G22853 | G7840 | G25799 | G8609 | G8829 | G5727 | G1361 | G23193 | G51094 | G25937 | G2819 | G5580 | G6573 | G5020 | G51141 | G208 | G7288 | G123775 | G134359 | G3973 | G84984 | G5340 | G1803 | G5159 | G10886 | K(ATP) Channel (nonspecified subtype) | G142 | G374875 | G796 | G607 | G4170 | G2746 | G3123 | G4547 | G7046 | G23621 | G1362 | G3762 | G706 | G2101 | G5140 | G27198 | G121278 | Retinoid acid receptor (nonspecified subtype) | G6711 | G2256 | G57007 | G7076 | G497258 | G2919 | Heme Oxygenase (HO) (nonspecified subtype) | Trypsin (nonspecified subtype) | G135 | G153 | G1573 | G6850 | G6885 | G6910 | G4609 | G231 | G54677 | sigma Receptor (nonspecified subtype) | P40594 | 17-beta-Hydroxysteroid dehydrogenase (nonspecified subtype) | G5054 | G841 | G10239 | G55911 | G3062 | G58155 | G60481 | G4985 | G53831 | G10255 | G5536 | G57104 | G1131 | G1147 | G3605 | G140 | G65975 | G2830 | G586 | G1612 | G6799 | G467 | G4692 | G79958 | G101927169 | G6646 | Triacylglycerol Lipase (TG Lipase) (nonspecified subtype) | G1748 | G1812 | G7442 | G2538 | G10203 | CDK1/Cyclin B | G6387 | G5584 | G3215 | P12328 | G123920 | G104909134 | G130013 | G2103 | G8644 | G28999 | G55422 | G3990 | G7498 | G51099 | G10438 | G10724 | ADP/ATP Translocase (nonspecified subtype) | G27159 | G5455 | G993 | G6737 | G4914 | G23373 | E2F Transcription Factor (nonspecified subtype) | G6160 | G1749 | G680 | G412 | G2932 | Glycogen synthase kinase 3 (GSK-3) (nonspecified subtype) | G2690 | G9026 | G166929 | G9242 | G9759 | G5770 | G1230 | G2203 | G23417 | G5742 | G6616 | G2068 | G9429 | Transforming growth factor beta (nonspecified subtype) | G43 | G51043 | G80755 | G84539 | G3291 | DNA topoisomerase (nonspecified subtype) | Cytochrome P450 Enzymes (nonspecified subtype) | Dopamine receptor (nonspecified subtype) | G100505518 | G9971 | Carbonic Anhydrase V (nonspecified subtype) | Vasopressin Receptor (nonspecified subtype) | G4017 | G2033 | G2246 | G5315 | G5468 | G11253 | G6256 | G3953 | G6927 | G26009 | G407048 | G51347 | G101929710 | G5775 | G3480 | G10316 | G146923 | G222545 | G5069 | G84342 | G2660 | G55521 | Sterol O-acyltransferase (ACAT) (nonspecified subtype) | G1394 | G7166 | G5105 | G5346 | G54551 | G2869 | Cytohesin (nonspecified subtype) | G23028 | G107984884 | G623 | G230 | G7915 | G2475 | G84444 | Adrenoceptor (nonspecified subtype) | G6492 | G554251 | G10295 | Fructose-Bisphosphate Aldolase (nonspecified subtype) | G2166 | G79602 | G10494 | G10888 | G1116 | G3362 | G5934 | G6913 | G118426 | G6096 | Neuropeptides B/W receptor (nonspecified subtype) | G23408 | G23632 | G5167 | G2831 | G284252 | G3764 | G6652 | G2558 | G100505566 | G898 | G5868 | G1195 | CDK2/Cyclin A | G3784 | G3835 | G2260 | G2264 | G5138 | G100101467 | G32 | G116372 | G407049 | G7031 | G5300 | G2697 | Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase (SERCA) (nonspecified subtype) | G640 | Cannabinoid receptor (nonspecified subtype) | G6999 | G8761 | G100529239 | G886 | Sodium channel (nonspecified subtype) | G4835 | G7547 | G1027 | G6257 | Heat shock protein 70 (nonspecified subtype) | G6513 | G1559 | G2099 | P12186 | G2321 | G57761 | G63924 | Adenosine receptor (nonspecified subtype) | G747 | G50801 | G84251 | G8476 | G8843 | G10447 | G125919 | G3592 | P40377 | G3630 | G64344 | G6578 | G7097 | G773 | G23235 | G101928436 | G6555 | G100131827 | G100996338 | G9934 | G2834 | G91012 | G5602 | G2194 | G5292 | G9149 | G9340 | G7010 | G836 | G5444 | G9451 | G57016 | HTR1B | Inosine 5'-monophosphate dehydrogenase (IMPDH) (nonspecified subtype) | G2104 | G335 | 5-Hydroxytryptamine Receptor 2 (5-HT2) (nonspecified subtype) | Mitogen-Activated Protein Kinase (nonspecified subtype) | G57704 | G125958 | G199990 | G4881 | G768 | G777 | G54583 | G80031 | G5328 | G2984 | G11238 | G6414 | G6523 | G1513 | G153478 | G221935 | G3552 | Hypoxia-Inducible Factor Prolyl Hydroxylase (nonspecified subtype) | Muscarinic Acetylcholine Receptor (mAChR) (nonspecified subtype) | G4193 | G8019 | G219402 | G760 | G80034 | G2641 | G10411 | G9453 | G9672 | G414236 | G4303 | G3292 | Sphingomyelin synthase (nonspecified subtype) | G196 | G47 | G4846 | G27347 | G10988 | G59269 | CDK2/Cyclin E | G6755 | G406914 | G4318 | G8435 | G26052 | G3172 | Sterol Regulatory Element-Binding Protein (nonspecified subtype) | Cyclooxygenase (COX) (nonspecified subtype) | G2259 | G23564 | G259230 | G9572 | Large Conductance BK(Ca) Potassium Channel (Maxi K+ Channel) (nonspecified subtype) | G11335 | Angiotensin receptor (AT) (nonspecified subtype) | G219409 | G22808 | G84109 | G5305 | G9586 | G9805 | G6869 | G7350 | G2692 | G8678 | G5547 | G10855 | G1240 | G6258 | G64146 | G154 | G4160 | G197 | G55614 | G5588 | G339403 | alpha1-Adrenoceptor (nonspecified subtype) | G7157 | G4763 | G10525 | G56729 | G390992 | G3929 | G1355 | Bombesin receptor (nonspecified subtype) | G4067 | G861 | G10936 | G3269 | G3991 | G3416 | G79731 | G8195 | G1407 | G1453 | G6532 | G2167 | G53353 | G55539 | G125988 | G4682 | G23071 | G5406 | G2914 | 5-Hydroxytryptamine Receptor (nonspecified subtype) | G7490 | G7942 | G55486 | G10644 | G2863 | G338442 | G1508 | G186 | G50508 | G8654 | G2925 | Cyclin A (nonspecified subtype) | G619373 | G6372 | alpha-Amylase (nonspecified subtype) | G4837 | G834 | G2548 | G2625 | G8811 | G115 | G3558 | Retinoid RXR receptor (nonspecified subtype) | G221955 | G799 | G51060 | G257194 | G18 | G185 | G4864 | G266722 | G338 | P6348 | G7275 | G84870 | G10135 | G9807 | Collagen (nonspecified subtype) | G177 | G761 | G84451 | G2778 | G344022 | G1293 | G1395 | G23410 | G117245 | G156 | G79068 | G10000 | G5697 | G582 | G65980 | G1728 | G2169 | Nitric oxide synthase (NOS) (nonspecified subtype) | cGMP-inhibited 3',5'-cyclic phosphodiesterase 3 (PDE3) (nonspecified subtype) | G1545 | G23216 | G54658 | G2935 | G31 | G56923 | Transcription Factor TCF (nonspecified subtype) | G2847 | G128025 | G135644 | G3654 | G6517 | G2908 | G9228 | G7067 | G220 | G2488 | G8878 | G2840 | G91851 | G55799 | G5916 | Melanin-concentrating hormone (MCH) receptor (nonspecified subtype) | G2281 | G79738 | G10891 | G1113 | G23011 | G23217 | G2587 | G259232 | G29110 | G3358 | Ribosomal Protein S6 Kinase, 70kDa (p70S6K) (nonspecified subtype) | G3667 | G5581 | G1524 | 11beta-Hydroxysteroid Dehydrogenase (nonspecified subtype) | G1141 | G134864 | G6546 | G5071 | G1401 | G367 | G1585 | G79071 | G5408 | G9641 | G1387 | Melanocortin receptor (nonspecified subtype) | G6506 | G2534 | G5788 | G6347 | Mitogen-activated protein kinase (JNK) (nonspecified subtype) | G3992 | G8289 | G2572 | G2780 | G10645 | G5781 | G2019 | G5290 | G2621 | G2944 | G3356 | P24924 | G6311 | G83756 | G107986362 | G3352 | G4161 | G23643 | G283450 | G9575 | G9718 | alpha-Mannosidase (nonspecified subtype) | G1814 | G201965 | G5139 | G51548 | G54596 | G1129 | Acyl-CoA Synthetase Short-Chain (nonspecified subtype) | G1215 | G8989 | Epoxide Hydrolase (nonspecified subtype) | G3570 | G2034 | G84930 | G283120 | Voltage-Gated Calcium Channel alpha-2/delta (nonspecified subtype) | G340061 | G3481 | Rho kinase (ROCK) (nonspecified subtype) | G407004 | G7351 | G917 | G3293 | G59340 | G4282 | G4843 | G50943 | G5021 | G5607 | G5891 | G1234 | G5979 | G161829 | G7421

The "Target / Biomarker Review Report" is a comprehensive and customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about the Target(s) / Biomarker(s) of your choice related to Obesity, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

Other Diseases

Obesity, Morbid | Obsessive-compulsive Disorder | Occipital Neuralgia | Ocular Albinism Type 1 | Ocular Hypertension | Ocular Surface Squamous Neoplasia | Oculocutaneous Albinism | Oculocutaneous Albinism Type 1 | Oculocutaneous Albinism Type 2 | Oculocutaneous Albinism Type 4 | Oculodentodigital Dysplasia | Oculopharyngeal Muscular Dystrophy | Odonto-onycho-dermal Dysplasia | Oguchi Disease-2 | Okihiro Syndrome | Oligoasthenoteratozoospermia | Oligoastrocytoma | Oligodendroglioma | Oligospermia | Ollier Disease | Olmsted Syndrome | Omenn Syndrome | Onchocerciasis | Open-angle Glaucoma | Ophthalmia, Sympathetic | Ophthalmoplegia | Opisthorchiasis | Optic Atrophy 2 | Optic Nerve Diseases | Optic Nerve Hypoplasia, Bilateral | Optic Neuritis | Optic Neuropathy | Optic Neuropathy, Anterior Ischemic | Oral Lichen Planus | Ornithine Transcarbamylase Deficiency | Orotic Aciduria | Orthostatic Intolerance | Osmotic Demyelination Syndrome | Osteitis | Osteoarthritis | Osteochondroma | Osteochondrosis | Osteogenesis Imperfecta | Osteogenesis Imperfecta Type I | Osteogenesis Imperfecta Type II | Osteogenesis Imperfecta Type III | Osteogenesis Imperfecta Type IV | Osteogenesis Imperfecta Type V | Osteogenesis Imperfecta Type VI | Osteoglophonic Dysplasia | Osteomalacia | Osteomyelitis | Osteonecrosis | Osteonecrosis Of The Jaw | Osteopathia Striata With Cranial Sclerosis | Osteopetrosis | Osteoporosis | Osteoporosis, Postmenopausal | Osteoporosis-pseudoglioma Syndrome | Osteosarcoma | Osteosclerosis | Otitis Externa | Otitis Media | Otopalatodigital Syndrome Type 2 | Otosclerosis | Ovarian Hyperstimulation Syndrome | Ovarian Sex Cord-stromal Tumor | Overactive Bladder | Pachyonychia Congenita | Paget's Disease Of The Breast | Pain | Palmoplantar Keratoderma | Palsy, Cerebral | Pancreatitis | Pancreatitis, Chronic | Pancytopenia | Panic Disorder | Panniculitis | Pantothenate Kinase-associated Neurodegeneration | Panuveitis | Papilledema | Papilloma | Papillon-Lefevre Syndrome | Papillorenal Syndrome | Papulopustular Rosacea | Paracoccidioidomycosis | Paraganglioma | Paraganglioma, Carotid Body | Paraplegia | Parapsoriasis | Parkinson Disease 6, Autosomal Recessive Early-onset | Parkinson's Disease | Parkinsonism | Paronychia | Paroxysmal Kinesigenic Dyskinesia | Paroxysmal Nocturnal Hemoglobinuria | Partington Syndrome | Parvovirus B19 Infection | PASLI Disease | Patent Ductus Arteriosus | Patent Foramen Ovale | Paternal Uniparental Disomy Of Chromosome 14 | Pathological Gambling | Pearson Syndrome | Peeling Skin Syndrome Type B | Peeling Skin Syndrome, Acral Type | Pelizaeus-Merzbacher Disease | Pelvic Inflammatory Disease | Pemphigoid | Pemphigus | Pemphigus Foliaceus | Pemphigus Vulgaris | Pendred Syndrome | Pericarditis | Periodic Limb Movement Disorder | Periodontitis | Peripheral Neuropathy | Peripheral T-cell Lymphoma | Peritonitis | Perivascular Epithelioid Cell Tumor | Periventricular Leukomalacia | Periventricular Nodular Heterotopia | Pernicious Anemia | Peroxisomal Disorder | Perry Syndrome | Persistent Fetal Circulation | Persistent Hyperplastic Primary Vitreous | Persistent Mullerian Duct Syndrome | Persistent Truncus Arteriosus | Personality Disorders | Peters-plus Syndrome | Peutz-Jeghers Syndrome | Peyronie's Disease | Pfeiffer Syndrome | PHARC Syndrome | Phenylketonuria | Phenylketonuria II | Pheochromocytoma | Phosphoenolpyruvate Carboxykinase Deficiency, Cytosolic | Phosphoglycerate Dehydrogenase Deficiency | Photosensitivity | Pierpont Syndrome | Pierre Robin Syndrome | Pierson Syndrome | Pigment Dispersion Syndrome | Pilomatrix Carcinoma | Pineoblastoma | Pitt-Hopkins Syndrome | Pituitary Disorders | Pituitary Dwarfism | Pituitary Stalk Interruption Syndrome | Pityriasis Rubra Pilaris | Placenta Previa | Plasma Cell Dyscrasia | Plasma Cell Leukemia | Plasmacytoma | Platelet Disorders | Platyspondylic Lethal Skeletal Dysplasia, Torrance Type | Pleomorphic Xanthoastrocytoma | Pleural Tuberculosis | Pleurisy | Pneumococcal Meningitis | Pneumoconiosis | Pneumonia, Bacterial | Pneumonia, Mycoplasma | Pneumonia, Viral | Pneumothorax | POEMS Syndrome | Poikiloderma With Neutropenia | Poirier-Bienvenu Neurodevelopmental Syndrome | Polyarteritis Nodosa | Polycystic Kidney, Autosomal Dominant | Polycystic Kidney, Autosomal Recessive | Polycystic Liver | Polycystic Ovary Syndrome | Polycythemia | Polycythemia Vera | Polydactyly | Polymicrogyria | Polymyalgia Rheumatica | Polymyositis | Polyneuropathy | Polyomavirus Nephropathy | Polyradiculopathy | Pompe Disease | Pontocerebellar Hypoplasia | Pontocerebellar Hypoplasia Type 2 | Pontocerebellar Hypoplasia Type 7 | Porencephaly | Poretti-Boltshauser Syndrome | Porokeratosis | Porphyria | Porphyria Cutanea Tarda | Porphyria, Acute Intermittent | Porphyria, Variegate | Portal Vein Thrombosis | Postaxial Polydactyly | Posterior Polar Cataract | Postpartum Depression | Postpoliomyelitis Syndrome | Potocki-Shaffer Syndrome | Pouchitis | Prader-Willi Syndrome | Pre-eclampsia | Preaxial Polydactyly | Precocious Puberty | Prediabetes | Pregnancy, Ectopic | Premature Ejaculation | Premenstrual Syndrome | Presbycusis | Presbyopia | Priapism | Primary Aldosteronism | Primary Biliary Cholangitis | Primary Carnitine Deficiency | Primary Cutaneous Amyloidosis | Primary Erythromelalgia | Primary Familial Brain Calcification | Primary Hyperoxaluria | Primary Hyperoxaluria Type 1 | Primary Hyperoxaluria Type 3 | Primary Lateral Sclerosis | Primary Ovarian Insufficiency | Primary Pigmented Nodular Adrenocortical Disease | Primary Progressive Aphasia | Primary Progressive Nonfluent Aphasia | Primary Sclerosing Cholangitis | Primary Torsion Dystonia | Primrose Syndrome | Proctitis | Progressive Encephalopathy-optic Atrophy Syndrome | Progressive External Ophthalmoplegia | Progressive Familial Intrahepatic Cholestasis | Progressive Familial Intrahepatic Cholestasis Type 1 | Progressive Familial Intrahepatic Cholestasis Type 2 | Progressive Familial Intrahepatic Cholestasis Type 3 | Progressive Myoclonic Epilepsy | Progressive Osseous Heteroplasia | Prolactinoma | Prolidase Deficiency | Prolymphocytic Leukemia | Proopiomelanocortin Deficiency | Prostatitis | Proteasome-associated Autoinflammatory Syndrome 2 | Protein C Deficiency | Protein S Deficiency | Proteus Syndrome | Proximal Symphalangism | Prune Belly Syndrome | Prurigo Nodularis | Pseudo-pseudohypoparathyroidism | Pseudoachondroplasia | Pseudoexfoliation Syndrome | Pseudohermaphroditism | Pseudohypoaldosteronism | Pseudohypoparathyroidism Type 1A | Pseudohypoparathyroidism Type 1B | Pseudohypoparathyroidism Type 1C | Pseudohypoparathyroidism Type 2 | Pseudomyxoma Peritonei | Psoriasis | Pterygium | Pulmonary Alveolar Microlithiasis | Pulmonary Alveolar Proteinosis | Pulmonary Capillary Hemangiomatosis | Pulmonary Sclerosing Hemangioma | Pulmonary Stenosis | Pulmonary Tuberculosis | Pulmonary Vein Stenosis | Pulmonary Veno-occlusive Disease | Pulverulent Zonular Cataract | Pupil Disorders | Pure Autonomic Failure | Pure Red Cell Aplasia | Purpura | Purpura, Thrombotic Thrombocytopenic | Pycnodysostosis | Pyelonephritis | Pyloric Stenosis, Infantile Hypertrophic | Pyoderma Gangrenosum | Pyruvate Carboxylase Deficiency Disease | Pyruvate Decarboxylase Deficiency | Pyruvate Dehydrogenase Deficiency | Pyruvate Kinase Deficiency | Raine Syndrome | Rash | Raynaud Phenomenon | Recurrent Respiratory Papillomatosis | Reflex Epilepsy | Relapsing Polychondritis | REM Sleep Behavior Disorder | Renal Dysplasia | Renal Failure | Renal Hypomagnesemia 3 | Renal Hypouricemia | Renal Medullary Carcinoma | Renal Oncocytoma | Renal Tubular Acidosis | Renal Tubular Dysgenesis | Renal-hepatic-pancreatic Dysplasia | Renpenning Syndrome | Restless Legs Syndrome | Restrictive Dermopathy | Reticular Dysgenesis | Retinal Coloboma | Retinal Degeneration | Retinal Detachment | Retinal Diseases | Retinal Dystrophy | Retinal Dystrophy, Early-onset Severe | Retinal Telangiectasia | Retinal Vasculitis | Retinitis | Retinitis Pigmentosa | Retinitis Pigmentosa 3 | Retinoblastoma | Retinopathy Of Prematurity | Retinopathy, Diabetic | Retinoschisis | Rett Syndrome | Reye Syndrome | Rhabdoid Tumor | Rhabdomyosarcoma | Rhabdomyosarcoma, Alveolar | Rhabdomyosarcoma, Embryonal | Rheumatic Heart Disease | Rheumatoid Arthritis | Rhinitis | Rhizomelic Chondrodysplasia Punctata | Riboflavin Transporter Deficiency Neuronopathy | Richter's Syndrome | Rickets | Rift Valley Fever | Roberts Syndrome | Robinow Syndrome | Rolandic Epilepsy | Rosacea | Rothmund-Thomson Syndrome | Rotor Syndrome | Rubeosis Iridis | Rubinstein-Taybi Syndrome | Saethre-Chotzen Syndrome | Salla Disease | Sandhoff Disease | SAPHO Syndrome | Sarcoidosis | Sarcoidosis, Pulmonary | Sarcoma | Sarcoma, Alveolar Soft Part | Sarcoma, Endometrial Stromal | Sarcoma, Ewing | Sarcomatoid Carcinoma Of The Lung | Sarcosinemia | Saul-Wilson Syndrome | Scabies | Scapuloperoneal Myopathy, X-linked Dominant | Scapuloperoneal Spinal Muscular Atrophy | Schaaf-Yang Syndrome | Schamberg Disease | Schindler Disease | Schistosomiasis | Schistosomiasis Mansoni | Schizencephaly | Schizoaffective Disorder | Schizophrenia | Schizophrenia, Paranoid | Schizotypal Personality Disorder | Schnitzler Syndrome | Schnyder Crystalline Corneal Dystrophy | Schuurs-Hoeijmakers Syndrome | Schwannoma | Schwannomatosis | Schwartz-Jampel-Aberfeld Syndrome | Scleritis | Sclerocornea | Scleroderma | Scleroderma, Diffuse | Sclerosing Cholangitis | Sclerosteosis | Sclerosteosis 2 | Scoliosis | Seasonal Mood Disorder | Seborrheic Dermatitis | Seizures | Seizures-scoliosis-macrocephaly Syndrome | Seminoma | Sengers Syndrome | Senior-Loken Syndrome | Sensorineural Hearing Loss | Sensory Ataxic Neuropathy, Dysarthria, And Ophthalmoparesis | Sensory Neuropathy | Sepiapterin Reductase Deficiency | Sertoli Cell-only Syndrome | Sezary Syndrome | Shock, Cardiogenic | Short-chain Acyl-CoA Dehydrogenase Deficiency | Shprintzen-Goldberg Syndrome | Shwachman-Bodian-Diamond Syndrome | Sialidosis